AKT1 and colonic neoplasm: A different study, however, showed that TP53TG1 is a tumor suppressor by inhibiting the activation of the PI3K/Akt pathway to enhance the sensitivity of colon cancer cells to PI3K inhibitor KU-55933 and AKT inhibitor perifosine [25].